Problem statement: Answer the MCQ question.
Query: Which drug has a 37.281% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1ccc(N2C(=O)[C@@H]3[C@@H]4O[C@@H]([C@H]5ON=C(c6ccc(Cl)cc6Cl)[C@H]54)[C@@H]3C2=O)cc1
b) CC(C(=O)O)n1c(-c2ccn[nH]2)n[nH]c1=S
Answer: b. CC(C(=O)O)n1c(-c2ccn[nH]2)n[nH]c1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C(=O)O)n1c(-c2ccn[nH]2)n[nH]c1=S
CC(C(=O)O)n1c(-c2ccn[nH]2)n[nH]c1=S
2-[3-(1H-pyrazol-5-yl)-5-sulfanylidene-1H-1,2,4-triazol-4-yl]propanoic acid